Citation: A. Shakespeare et G. Simeon, ECONOMIC-ANALYSIS OF EPILEPSY TREATMENT - A COST MINIMIZATION ANALYSIS COMPARING CARBAMAZEPINE AND LAMOTRIGINE IN THE UK, Seizure, 7(2), 1998, pp. 119-125
Authors:
WILKINSON D
DUBOIS B
SHAKESPEARE A
MCKEITH I
SHIKIAR R
DARTIGUES JF
SAGNIER PP
Citation: D. Wilkinson et al., THE EFFECT OF METRIFONATE ON THE BURDEN TO CAREGIVERS OF PATIENTS WITH ALZHEIMERS-DISEASE, Journal of the American Geriatrics Society, 46(9), 1998, pp. 201-201
Authors:
HUTTON J
BROWN R
BOROWITZ M
ABRAMS K
ROTHMAN M
SHAKESPEARE A
Citation: J. Hutton et al., A NEW DECISION-MODEL FOR COST-UTILITY COMPARISONS OF CHEMOTHERAPY IN RECURRENT METASTATIC BREAST-CANCER, PharmacoEconomics, 9, 1996, pp. 8-22
Citation: Da. Revicki et al., PREFERENCES FOR SCHIZOPHRENIA-RELATED HEALTH STATES - A COMPARISON OFPATIENTS, CAREGIVERS AND PSYCHIATRISTS, International clinical psychopharmacology, 11(2), 1996, pp. 101-108
Authors:
SIMPSON K
HATZIANDREU EJ
ANDERSSON F
SHAKESPEARE A
OLEKSY I
TOSTESON ANA
Citation: K. Simpson et al., COST-EFFECTIVENESS OF ANTIVIRAL TREATMENT WITH ZALCITABINE PLUS ZIDOVUDINE FOR AIDS PATIENTS WITH CD4-THAN 300( COUNTS LESS)MU-1 IN 5 EUROPEAN COUNTRIES/, PharmacoEconomics, 6(6), 1994, pp. 553-562